AUTL
Autolus Therapeutics
AUTL
AUTL
55 hedge funds and large institutions have $177M invested in Autolus Therapeutics in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.05% less ownership
Funds ownership: 29.89% → 29.84% (-0.05%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
55
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$27.7M | |
| 2 | +$6.51M | |
| 3 | +$3.14M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$2.29M |
| 5 |
JPMorgan Chase & Co
New York
|
+$504K |
Top Sellers
| 1 | -$9.5M | |
| 2 | -$2.75M | |
| 3 | -$1.31M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$859K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$620K |